AgonOx Revenue and Competitors
Estimated Revenue & Valuation
- AgonOx's estimated annual revenue is currently $930k per year.
- AgonOx's estimated revenue per employee is $155,000
Employee Data
- AgonOx has 6 Employees.
- AgonOx grew their employee count by 0% last year.
AgonOx's People
| Name | Title | Email/Phone |
|---|
AgonOx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -54% | N/A | N/A |
#2 | $18.8M | 121 | 11% | N/A | N/A |
#3 | $6.8M | 44 | 7% | N/A | N/A |
#4 | $0.8M | 5 | 0% | N/A | N/A |
#5 | $35.8M | 185 | 38% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $2.6M | 17 | 0% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $8.1M | 52 | 4% | N/A | N/A |
#10 | $0.8M | 5 | 0% | N/A | N/A |
What Is AgonOx?
AgonOx, Inc.is a spin-off company from the Providence Cancer Center located in Portland, Oregon. We are developing immune system activators for use in cancer therapy. Research in the field of T-cell modulation conducted worldwide with OX40 and other agents has demonstrated that the use of T-cell modulating therapies in combination with specific anti-tumor therapies have the potential for yielding therapeutic benefits for patients with cancer. AgonOx is focused on the development of immune system modulators in combination with other promising agents in the immune oncology space.
keywords:N/A
N/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Portland
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 6 | -25% | N/A |
#2 | $0.4M | 6 | N/A | N/A |
#3 | $0.4M | 6 | N/A | N/A |
#4 | $0.4M | 6 | N/A | N/A |
#5 | $0.4M | 6 | N/A | N/A |